These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15883499)

  • 1. [Circadian variations in intraocular pressure and their clinical implications].
    Blaise P; Guillaume S
    J Fr Ophtalmol; 2005 Mar; 28(3):317-25. PubMed ID: 15883499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.
    Mishima HK; Kiuchi Y; Takamatsu M; Rácz P; Bito LZ
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S139-44. PubMed ID: 9154290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four years later: a clinical update on latanoprost.
    Ravinet E; Mermoud A; Brignoli R
    Eur J Ophthalmol; 2003 Mar; 13(2):162-75. PubMed ID: 12696636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
    Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model-based meta-analysis of the effect of latanoprost chronotherapy on the circadian intraocular pressure of patients with glaucoma or ocular hypertension.
    Luu KT; Raber SR; Nickens DJ; Vicini P
    Clin Pharmacol Ther; 2010 Apr; 87(4):421-5. PubMed ID: 20164834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
    Mansouri K; Orguel S; Mermoud A; Haefliger I; Flammer J; Ravinet E; Shaarawy T
    Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of latanoprost on aqueous humor PGF2alpha levels in glaucoma patients.
    Güven D; Karakurt A; Saban E; Hasiripi H
    Int Ophthalmol; 1999; 23(2):91-6. PubMed ID: 11196126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
    Nomura S; Hashimoto M
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment.
    Greve EL; Rulo AH; Drance SM; Crichton AC; Mills RP; Hoyng PF
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S89-92. PubMed ID: 9154282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
    Konstas AG; Lake S; Maltezos AC; Holmes KT; Stewart WC
    Eye (Lond); 2001 Feb; 15(Pt 1):59-62. PubMed ID: 11318297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.
    Nordmann JP; Berdeaux G
    Clin Ther; 2007 Aug; 29(8):1751-60; discussion 1750. PubMed ID: 17919556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
    Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
    Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma.
    Evans DW; Bartlett JD; Houde B; Than TP; Shaikh A
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):224-9. PubMed ID: 18355134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.